Literature DB >> 778263

Eosinophil chemotactic factor (ECF). I. Release from polymorphonuclear leukocytes by the calcium ionophore A23187.

B M Czarnetzki, W König, L M Lichtenstein.   

Abstract

Eosinophil chemotactic factor (ECF), previously thought to be primarily associated with human basophils and mast cells, could be released from human neutrophils (PMN) and eosinophils but not lymphocytes by the calcium ionophore A23187. Release of ECF from PMN was time and dose-dependent. Like antigen-induced, basophil-derived ECF, PMN-derived ECF had a high selectivity for eosinophils as determined by differential counts of migrating cells and by deactivation studies. Chromatographic analysis of PMN-derived ECF on Sephadex G-25 showed an elution pattern very similar to that of basophil-derived ECF. With rat peritoneal cells, it was possible to show that mast cells as well as mast cell-depleted cell preparations could be induced to release an ECF that appears to be similar or identical to human ECF. These findings suggest that ECF may play a role in inflammatory processes involving cells other than basophils and mast cells.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 778263

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  18 in total

1.  Comparison of the generation in vitro of chemotactically active LTB4 and its omega-metabolites by human neutrophils and lymphocytes/monocytes.

Authors:  T Rosenbach; B M Czarnetzki
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

2.  Subcellular localization of the eosinophil chemotactic factor (ECF) and its inactivator in human polymorphonuclear leucocytes (PMN).

Authors:  N Frickhofen; W König
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

3.  Generation and secretion of eosinophilotactic activity from human polymorphonuclear neutrophils by various mechanisms of cell activation.

Authors:  W König; N Frickhofen; H Tesch
Journal:  Immunology       Date:  1979-04       Impact factor: 7.397

4.  Cytochrome P-450-dependent production of chemotactic arachidonate metabolites from human neutrophils.

Authors:  B M Czarnetzki; G Goerz; K Bolsen; H Merk
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

5.  Development of human connective tissue mast cells from purified blood monocytes.

Authors:  B M Czarnetzki; C G Figdor; G Kolde; T Vroom; R Aalberse; J E de Vries
Journal:  Immunology       Date:  1984-03       Impact factor: 7.397

6.  Release of lipoxygenase products of arachidonic acid from freshly isolated human keratinocytes.

Authors:  J Grabbe; B M Czarnetzki; M Mardin
Journal:  Arch Dermatol Res       Date:  1984       Impact factor: 3.017

7.  Mast cell-mediated reactions of host defense and tissue injury: the regulatory role of eosinophil polymorphonuclear leukocytes.

Authors:  E J Goetzl
Journal:  Inflammation       Date:  1977-09       Impact factor: 4.092

8.  Lung injury mediated by antibodies to endothelium. II. Study of the effect of repeated antigen-antibody interactions in rabbits tolerant to heterologous antibody.

Authors:  G Camussi; P R Caldwell; G Andres; J R Brentjens
Journal:  Am J Pathol       Date:  1987-05       Impact factor: 4.307

9.  Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances. A histochemical, biochemical, and electron microscopic study.

Authors:  H Popper; G Knipping; B M Czarnetzki; R Steiner; G Helleis; H Auer
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

10.  Effect of cations on leukotriene release: requirements for the metabolism of peptido-leukotrienes (leukotrienes C4, D4) by human polymorphonuclear granulocytes.

Authors:  M Raulf; M Stüning; W König
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.